SCHEMBL6504836

SCHEMBL6504836

CCCc1ccc(-n2cc(NC(N)=O)c(C(N)=O)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITK Q08881 1/20 0.43
PARP1 P09874 10/20 0.42
PARP2 Q9UGN5 3/20 0.42
PARP3 Q9Y6F1 3/20 0.42
KDM4E B2RXH2 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HTT P42858 1/20 0.40
HIF1A Q16665 1/20 0.40
EPAS1 Q99814 1/20 0.40
ABCB1 P08183 2/20 0.39
ABCG2 Q9UNQ0 2/20 0.39
ALDH1A1 P00352 2/20 0.39
GAA P10253 2/20 0.39
MAPT P10636 2/20 0.39
POLB P06746 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
LMNA P02545 1/20 0.37
NPC1 O15118 1/20 0.37
PKM P14618 1/20 0.37
RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6533612 0.92 ITK (0.41) ITKPARP1HIF1AEPAS1ALDH1A1
SCHEMBL6469794 0.83 LMNA (0.47) ITKKDM4ESMN1; SMN2HTTALDH1A1
SCHEMBL6506596 0.82 KDM4E (0.41) ITKPARP1PARP2PARP3KDM4E
SCHEMBL6506767 0.82 ITK (0.48) ITKPARP1KDM4ESMN1; SMN2HTT
SCHEMBL6467527 0.80 KDM4E (0.47) ITKPARP1KDM4ESMN1; SMN2HTT
SCHEMBL6469788 0.80 KMT2A (0.46) ITKKDM4ESMN1; SMN2HTTALDH1A1
SCHEMBL6465833 0.80 ALDH1A1 (0.53) ITKPARP1PARP2PARP3KDM4E
SCHEMBL6466511 0.80 ITK (0.44) ITKPARP1PARP2PARP3KDM4E
SCHEMBL6498196 0.80 ITK (0.42) ITKPARP1SMN1; SMN2ALDH1A1MAPT
SCHEMBL6469937 0.80 ITK (0.49) ITKPARP1PARP2PARP3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation PHARMACIA AND UPJOHN COMPANY LLC 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation IL4, ARG2, CASP4 ITK 4236/4885PARP1 1904/4885PARP2 1481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.